{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:30:39Z","timestamp":1783042239819,"version":"3.54.6"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15233-2","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:50:41Z","timestamp":1764075041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["NOTCH1 mutation status as a prognostic biomarker in T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Hissa","family":"Al Kuwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Al Khinji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deema","family":"Al-Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullatif","family":"Al Hor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhafer","family":"Malouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javeed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"19","key":"15233_CR1","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1182\/blood-2011-02-334219","volume":"118","author":"RB Abdelali","year":"2011","unstructured":"Abdelali RB, et al. Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1\/FBXW7 mutations, but not of low ERG\/BAALC expression: a GRAALL study. Blood. 2011;118(19):5099\u2013107.","journal-title":"Blood"},{"key":"15233_CR2","unstructured":"Aref S. Significance of notch1 mutations detections in t-acute lymphoblastic leukemia patients. Cancer Biomarkers. 2019. pages 1\u20136."},{"issue":"3","key":"15233_CR3","first-page":"125","volume":"13","author":"S Aref","year":"2020","unstructured":"Aref S, et al. Controversial prognostic impact of notch1 mutations in t-all. Hematol Oncol Stem Cell Ther. 2020;13(3):125\u201332.","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"10","key":"15233_CR4","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3324\/haematol.2008.005272","volume":"94","author":"CD Baldus","year":"2009","unstructured":"Baldus CD, Thibaut J, Goekbuget N, Stroux A, Schlee C, Mossner M, et al. Prognostic implications of notch1 and fbxw7 mutations in adult acute T-lymphoblastic leukemia. Haematologica. 2009;94(10):1383\u201390.","journal-title":"Haematologica"},{"issue":"1","key":"15233_CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13045-021-01200-4","volume":"14","author":"A Bardelli","year":"2021","unstructured":"Bardelli A, et al. T-cell acute lymphoblastic leukemia: epidemiology and pathogenesis. J Hematol Oncol. 2021;14(1):187.","journal-title":"J Hematol Oncol"},{"key":"15233_CR6","unstructured":"Ben Abdelali R. Frequency of notch-1 mutations in t-all adult patients. Blood. 2011. LALA-94 and GRAALL-2003 trial."},{"key":"15233_CR7","unstructured":"Bonn BR. Notch-1 mutations in pediatric patients with t-lbl. J Clin Oncol. 2013. ALL-BFM-type treatment strategy."},{"key":"15233_CR8","unstructured":"Callens C. Notch-1 mutations in french patients younger than 20 years with t-lbl. J Clin Oncol. 2011; Berlin-Frankfurt-Munich\u2013ALL\u2013type protocol."},{"issue":"9","key":"15233_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/17474086.2021.1967137","volume":"14","author":"F Ceppi","year":"2021","unstructured":"Ceppi F, Rizzati F, Colombini A, Conter V, Cazzaniga G. Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia. Expert Rev Hematol. 2021;14(9):795\u2013807.","journal-title":"Expert Rev Hematol"},{"issue":"12","key":"15233_CR10","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1038\/leu.2010.205","volume":"24","author":"E Clappier","year":"2010","unstructured":"Clappier E, et al. Notch1 and fbxw7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with t-cell acute lymphoblastic leukemia (t-all) treated on eortc trials 58881 and 58951. Leukemia. 2010;24(12):2023\u201331.","journal-title":"Leukemia"},{"issue":"9","key":"15233_CR11","first-page":"1157","volume":"129","author":"K De Keersmaecker","year":"2017","unstructured":"De Keersmaecker K, et al. Complex interactions of notch1 signaling in t-all. Blood. 2017;129(9):1157\u201366.","journal-title":"Blood"},{"key":"15233_CR12","unstructured":"Fogelstrand L. Notch-1 mutations in children with t-all. Br J Haematology 2014;. (NOPHO) ALL-1992 and ALL-2000 protocols."},{"issue":"1","key":"15233_CR13","first-page":"51","volume":"38","author":"C Gao","year":"2014","unstructured":"Gao C, et al. Notch1 mutations and improved treatment response in t-all. Leuk Res. 2014;38(1):51\u20136.","journal-title":"Leuk Res"},{"issue":"11","key":"15233_CR14","first-page":"971","volume":"21","author":"L Gharaibeh","year":"2020","unstructured":"Gharaibeh L, et al. Fbxw7 mutations and their role in Notch1 degradation. Cancer Biol Ther. 2020;21(11):971\u201380.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"15233_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-023-05450-9","volume":"103","author":"S Guo","year":"2024","unstructured":"Guo S, et al. Prognostic significance of notch1 mutations in t-all. Ann Hematol. 2024;103(1):1\u201312.","journal-title":"Ann Hematol"},{"issue":"10","key":"15233_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011213","volume":"4","author":"R Kopan","year":"2012","unstructured":"Kopan R. Notch signaling. Cold Spring Harb Perspect Biol. 2012;4(10):a011213.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"15233_CR17","unstructured":"Kox C. Notch-1 mutations in children with t-all. Leukemia. ALL\u2013BFM 2000. 2010."},{"issue":"26","key":"15233_CR18","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1200\/JCO.2009.22.0996","volume":"27","author":"MR Mansour","year":"2009","unstructured":"Mansour MR, Sulis ML, Duke V, Foroni L, Jenkinson S, Koo K, et al. Prognostic implications of notch1 and fbxw7 mutations in adults with t-cell acute lymphoblastic leukemia treated on the mrc ukallxii\/ecog e2993 protocol. J Clin Oncol. 2009;27(26):4352\u20136.","journal-title":"J Clin Oncol"},{"issue":"579","key":"15233_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-014-0579-0","volume":"14","author":"AM Methley","year":"2014","unstructured":"Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S. Pico, picos and spider: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014;14(579):579.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"15233_CR20","first-page":"277","volume":"43","author":"L Pagliaro","year":"2024","unstructured":"Pagliaro L, et al. Constitutive activation of notch1 signaling in leukemic transformation. Oncogene. 2024;43(4):277\u201387.","journal-title":"Oncogene"},{"issue":"2","key":"15233_CR21","first-page":"197","volume":"26","author":"T Palomero","year":"2014","unstructured":"Palomero T, et al. Notch1 and myc in oncogenic transformation. Cancer Cell. 2014;26(2):197\u2013210.","journal-title":"Cancer Cell"},{"issue":"13","key":"15233_CR22","first-page":"2100","volume":"139","author":"F Pozzo","year":"2022","unstructured":"Pozzo F, et al. Activating mutations in notch1 in T-ALL. Blood. 2022;139(13):2100\u201312.","journal-title":"Blood"},{"issue":"2","key":"15233_CR23","first-page":"137","volume":"124","author":"H Sade","year":"2004","unstructured":"Sade H, et al. Pi3K-Akt-mTOR pathway in leukemia progression. Br J Haematol. 2004;124(2):137\u201345.","journal-title":"Br J Haematol"},{"issue":"3","key":"15233_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/2040620712471368","volume":"4","author":"V Tosello","year":"2013","unstructured":"Tosello V, Ferrando AA. The notch signaling pathway: role in the pathogenesis of t-cell acute lymphoblastic leukemia and implication for therapy. Ther Adv Hematol. 2013;4(3):199\u2013210.","journal-title":"Ther Adv Hematol"},{"key":"15233_CR25","unstructured":"Trinquand A. Notch-1 mutations in adults with t-all. Blood. 2013; GRAALL-2005."},{"key":"15233_CR26","volume":"117","author":"D Verma","year":"2024","unstructured":"Verma D, et al. Notch1 signaling in t-cell differentiation and proliferation. Cell Signal. 2024;117:111026.","journal-title":"Cell Signal"},{"key":"15233_CR27","volume":"112","author":"H Yin","year":"2022","unstructured":"Yin H, et al. Challenges in T-ALL treatment: relapse rates and survival outcomes. Leuk Res. 2022;112:106745.","journal-title":"Leuk Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15233-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15233-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15233-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:50:47Z","timestamp":1764075047000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15233-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15233"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15233-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a systematic review and meta-analysis of previously published studies and does not involve new data collection from human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1820"}}